YY1 and nonpapillary renal cell carcinoma: In clear cell renal cell carcinoma, the YY1/HDAC2 complex reduces the expression of YTHDC1, which modulates the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway38.